In-vitro Pharmacology of Sarpogrelate and the Enantiomers of its Major Metabolite: 5-HT2A Receptor Specificity, Stereoselectivity and Modulation of Ritanserin-induced Depression of 5-HT Contractions in Rat Tail Artery
- 1 April 1995
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 47 (4) , 310-316
- https://doi.org/10.1111/j.2042-7158.1995.tb05801.x
Abstract
The new antiplatelet agent sarpogrelate (MCI-9042), its major metabolite (R,S)-1-[2-[2-(3-methoxyphe-nyl)ethyl]phenoxy]-3-(dimethylamino)-2-propanol ((R,S)-M-1) and the enantiomers of (R,S)-M-1 were studied as antagonists at 5-HT2A receptors, 5-HT1-like receptors, 5-HT3 receptors, α1-adrenoceptors, β-adrenoceptors, histamine H1 receptors, histamine H2 receptors and muscarinic M3 receptors in various functional in-vitro assays. Sarpogrelate, (R,S)-M-1, (S)-M-1 and (S)-M-1, respectively, were competitive antagonists of 5-hydroxytryptamine (5-HT) at 5-HT2A receptors of rat tail artery with calculated pA2 values of 8·53, 9·04, 9·00 and 8·81, respectively. Sarpogrelate lacked prominent 5-HTt like, 5-HT3, β, Ht, H2 and M3 antagonist activity and weakly blocked α1-adrenoceptors (pKB = 6·30). (S)-M-1 showed weak affinity for 5-HT1-like receptors (pKB = 6·30), α1 (pKB = 6·80) and β (pKB = 6·54) adrenoceptors, while (R)-M-1 was a weak antagonist at histamine H1 receptors (pKB = 6·49). Stereoselectivity of M-1 enantiomers was low. (R)-M-1 showed 1·6-fold, 2·3-fold and 2·5-fold higher antagonist activity than (S)-M-1 for 5-HT2A, H1 and M3 receptor, respectively. Affinity at β-adrenoceptors and 5-HT1-like receptors was 5-fold and 3-fold higher for (S)-M-1 than for (R)-M-1. The depression of the maximum effect of 5-HT-induced contractions of rat-tail artery which amounted to 58–72% in the presence of ritanserin (1 nm), was totally prevented after preincubation with sarpogrelate (1 μm) and (R)- and (S)-M-1 (30 and 300 nm), respectively, and partially prevented after preincubation with (R)- and (S)-M-1 (0·3-3 nm). (R)- and (S)-M-1 failed to differ in restoring the ritanserin-induced depression of the 5-HT maximum response. It is concluded that sarpogrelate, its major metabolite (R, S)-M-1 and M-1 enantiomers are specific antagonists of 5-HT at 5-HT2A receptors. The stereochemical configuration of the ligands does not seem to be crucial for binding to the 5-HT2A receptor. Like ketanserin, sarpogrelate and M-1 enantiomers appear to be allosteric activators of the 5-HT2A receptor system in rat tail artery.Keywords
This publication has 13 references indexed in Scilit:
- 5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1993
- MCI–9042, a New Antiplatelet Agent Is a Selective S2-Serotonergic Receptor AntagonistThrombosis and Haemostasis, 1991
- MCI-9042: High affinity for serotonergic receptors as assessed by radioligand binding assay.Journal of Pharmacobio-Dynamics, 1991
- 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Syntheses and platelet aggregation inhibitory and antithrombotic properties of [2-[(.omega.-Aminoalkoxy)phenyl]benzenesJournal of Medicinal Chemistry, 1990
- Allosteric properties of the 5-HT2 receptor system of the rat tail arteryNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
- Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human plateletsin vitroInflammation Research, 1986
- Tryptamine‐induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5‐hydroxytryptamine receptorsBritish Journal of Pharmacology, 1985
- Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Definition and Antagonism of Histamine H2-receptorsNature, 1972